Skip to Content
Merck
CN

T9700

Sigma-Aldrich

Monoclonal Anti-TWEAK Receptor/Fn-14 antibody produced in mouse

~2 mg/mL, clone TR-22, purified immunoglobulin, buffered aqueous solution

Synonym(s):

Anti-TNF-like Weak Inducer of Apoptosis Receptor

Sign Into View Organizational & Contract Pricing

Select a Size


About This Item

MDL number:
UNSPSC Code:
51111800
NACRES:
NA.41
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

TR-22, monoclonal

form

buffered aqueous solution

mol wt

antigen ~14 kDa

species reactivity

human

concentration

~2 mg/mL

technique(s)

flow cytometry: suitable
indirect ELISA: suitable
microarray: suitable
western blot: 2-4 μg/mL using HEK-293 overexpressing TWEAKR cells lysate

isotype

IgG1

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... TNFRSF12A(51330)

General description

Monoclonal Anti-TWEAK Receptor (mouse IgG1 isotype) is derived from the TR-22 hybridoma produced by the fusion of mouse myeloma cells (NS1) and splenocytes from BALB/c mice immunized with human TWEAK receptor. Tumor necrosis factor receptor superfamily member 12A or TNF-like weak inducer of apoptosis Receptor (TWEAKR) or fibroblast growth factor-inducible immediate-early response protein 14 (fn14) is a type I transmembrane receptor comprising transmembrane domain, amino-terminal signal peptide, and carboxy-terminal cytoplasmic domain. The TWEAKR gene is mapped to human chromosome 16p13.3. TWEAKR is expressed in the placenta, lungs, kidney, and heart.

Immunogen

synthetic peptide corresponding to amino acids 39-52 in the N-terminus of human TWEAK receptor.

Application

Monoclonal Anti-TWEAK Receptor/Fn-14 antibody produced in mouse is suitable for:
  • enzyme-linked immunosorbent assay (ELISA)
  • immunoblotting
  • flow cytometry

Biochem/physiol Actions

Fn14 induces growth effects in neurons independent of the ligand, TWEAK.
Monoclonal Anti-TWEAK receptor recognizes human TWEAK receptor

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Preparation Note

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. Storage in “frost-free” freezers is also not recom-mended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Katsuhisa Tanabe et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 23(29), 9675-9686 (2003-10-24)
For successful nerve regeneration, a coordinated shift in gene expression pattern must occur in axotomized neurons. To identify genes participating in axonal regeneration, we characterized mRNA expression profiles in dorsal root ganglia (DRG) before and after sciatic nerve transection. Dozens
Steven R Wiley et al.
Cytokine & growth factor reviews, 14(3-4), 241-249 (2003-06-06)
The cytokine tumor necrosis factor-like weak inducer of apoptosis (TWEAK) was initially described as a member of the tumor necrosis factor (TNF) superfamily in 1997. TWEAK is a cell surface-associated type II transmembrane protein, but a smaller, biologically active form

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service